loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r1_cep_2003_079___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 JANSSEN PHARMACEUTICA NV Beerse BE (1)

filter

01 Bromperidol decanoate (1)

filter

01 Belgium (1)

filter

01 Withdrawn by Holder (1)

URL Supplier Web Content
R1-CEP 2003-079 - Rev 02
Withdrawn by Holder
Chemical
2013-11-21
2022-07-13
1397
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-079 - Rev 02 of Janssen Pharmaceutica Nv Beerse Be

Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-079 - Rev 02 of Janssen Pharmaceutica Nv Beerse Be 1

20

Janssen Pharmaceutica Nv Beerse Be, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their significant offerings is Bromperidol decanoate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2003-079 - Rev 02

This Chemical Type CEP, issued on November 21, 2013, remains in force until July 13, 2022, ensuring its reliability within the pharmaceutical industry.

Substance Number 1397 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY